Wei et al. reported that miR-155 promotes insulin resistance in obese mice via targeting PPARγ [33], while Lin et al. reported that miR-155 inhibits insulin resistance in diabetic mice via several negative regulators (C/EBPβ, HDAC4, and SOCS1) [34]. Here, PPARG is linked to Insulin resistance.